Wave Eye Scouting 2020 Sip Club . . . 2020 "Healthy China Brand List" Value List was announced.

On August 14th, Zhongkang Research Institute released the 2020 China Pharmaceutical Brand List and Value Rankings at the Xipu Conference.
Top50 brand value to a new record high, on the list of brand value of the lowest threshold of more than 2 billion yuan! The 2020 Healthy China Brand List value list is based on the 2020 Healthy China Brand List of pharmaceutical brands brand value research, only to calculate its brand value in the Chinese market.
the top 50 brands for brand value based on model calculations.
strongest brand, the value of the top 50 brands significantly increased by 2020 top 50 brand value of up to 225.1 billion yuan, up 10% from last year's top 50 total value.
top 50 brand value reached 3.24 billion yuan, up 21% year-on-year.
top 50 brand value threshold raised to 2 billion yuan.
top 10 brand value threshold from last year's 5 billion yuan to 6 billion yuan.
Top3 brand is worth more than 10 billion yuan.
more than 5 billion yuan worth of brands reached 16, the cumulative total value of 124.4 billion yuan, accounting for 55% of the total value of the listed brands, the brand shows a strong trend.
Behind the increase in brand value, on the one hand, is the continuous expansion of China's pharmaceutical market capacity, as well as the new medical reform background of the health industry prospects, on the other hand, brand enterprises pay more and more attention to brand reputation and visibility, as well as quality and technological innovation.
the number of chemicals on the list increased, the total value of local brands above the foreign (joint) brand Top50 brand, chemicals on the list of 32 brands, the total value of 134.7 billion yuan, an increase of 19.3 billion yuan over last year.
four seats for the chemicals list, with local brands accounting for three.
value of the chemical brand mainly comes from "technology", the increase of the brand seat and value of chemical medicine means that China's pharmaceutical market attaches great importance to research and development capabilities, as well as the innovation of local enterprises and the improvement of core technology.
such as the national first-class new drug Erbip ®, through the consistency evaluation of the ®, with its dazzling market performance debuted in the 2020 value list.
26 local brands listed in 2020, with a total brand value of 114.3 billion yuan, 3.6 billion yuan higher than the total value of foreign brands, the total value of local brands for the first time over foreign (joint) brands.
the rise of local quality brands is rapidly changing the market trend.
The popularity of the old Chinese characters, the value of self-medicine products to enhance the value of the old Chinese characters with its long history of precipitation and continue to introduce new creations, expanding its brand influence, by the old and middle-young consumers welcome.
this year' East ® and Yunnan White ® still jointly ranked runner-up, a strong leader.
film ®, Ma Shouldlong® also performed brightly, in which the film ® brand added value of more than 1 billion yuan, leaping into the top 10 value list.
with the increase of consumer awareness of self-medication and the strengthening of corporate brand strategy, OTC brand value continues to grow.
Top50 brands, OTC brands ranked 22 with a total value of 98.7 billion yuan, an increase of 14.3 billion yuan over last year, contributing 70% of the increase in brand value.
2020 drug brand value list, slow disease drugs accounted for 24 seats, the total value of 112 billion yuan, accounting for nearly half of the total list.
chronic diseases such as anti-hypertrollers, anti-thrombosis drugs, blood lipid-lowering drugs, diabetes medications, liver and bile medications and anti-asthma drugs are among the Top10 categories in the value list.
foreign-funded enterprises in the use of chronic disease drugs still show strong strength and deep brand accumulation.
of the 24 chronically ill brands, foreign brands accounted for 16 seats and brand value accounted for 75%.
affected by the volume procurement policy, the price of drugs included in the collection catalogue generally decreased, the expected profit of slow-disease brand drugs decreased, and the brand value decreased.
, the overall value of chronic disease drugs in this year's value list has slowed, with the value share falling to 49.76 per cent from 53.52 per cent last year.
as the aging process of the population continues to intensify, the prevalence of chronic diseases such as cardiovascular and cerebrovascular diseases and diabetes is increasing year by year, and the use of chronic diseases is still the focus and core of the market.
1: Comparison of top 10 category values in the Healthy China Brand List 2020.
"2020 China Pharmaceutical Brand List - Value Rankings" Selection Rules Brief Description "Selection Objectives" measure the future benefits of the calculated brand for brand owner purely from the perspective of brand value;
Sample Selection is based on the 2020 Healthy China Brand List listed drug brands as a computational sample, the calculated value range is the same brand name in the same therapeutic field of individual or series products, the calculated value range is the Chinese market.
Theory System: M-DBV (Method of Drug Brand Value) Drug Brand Brand Calculation Method: V Drug Brand Value s V Future Earnings s V Brand Residual Value; V Future Earnings: Calculated Brand Revenue for Brand Owner in the Next 3 Years, Core Impact Factor is Brand Baseline V Brand Residual Value of 4D-BES Evaluation System: Brand Residual Value Brands After 10 Years of Calculated Brands Benchmark: Through the consumer U and A research to calculate the brand loyalty of a single brand, brand reputation and brand attention, and form a quantitative sum calculation year: the list released the previous year by calculating the 2020 "Healthy China Brand List" list of drug brand brand value, according to the brand value of the ranking, and for the top 50 to form the final list.
.